LUNGevity's 'No One Missed' campaign wants to raise lung cancer biomarker awareness, especially with traditionally underserved groups.

Lung can­cer bio­mark­er cam­paign, launched with As­traZeneca, boosts its reach and adds phar­ma sup­port­ers

The groups are called the MET Cru­saders, the EGFR Re­sis­tors, the KRAS Kick­ers and the ROS1ders — and mem­bers are non-small cell lung can­cer pa­tients who …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.